| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/27/2005 | EP1448207B1 Dosage regimen and pharmaceutical composition for emergency contraception |
| 04/27/2005 | EP1427430B1 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary system caused by sex hormones |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1289519A4 Methods of treating androgen deficiency in men using selective antiestrogens |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610664A 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 04/27/2005 | CN1610559A Prostaglandin composition for the treatment of erectile dysfunction |
| 04/27/2005 | CN1608670A Refreshing capsule and its prepn process |
| 04/27/2005 | CN1608664A Medicine and prepn for treating female's climacteric syndrome |
| 04/27/2005 | CN1608661A Capsule prepn for treating women's diseases and its prepn process |
| 04/27/2005 | CN1608639A Chinese angelica dripping pill and its prepn process |
| 04/27/2005 | CN1608633A Concentrated vegetable oil for treating male's premature ejaculation |
| 04/27/2005 | CN1608615A Fibrauretine-amino acid fluid for transfusion and its production process |
| 04/27/2005 | CN1608613A Fibrauretine powder for injection and its production process |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198825C 8-pheyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198804C Amide compounds and use thereof |
| 04/27/2005 | CN1198802C Chalcones having antiproliferactive activity |
| 04/27/2005 | CN1198801C Indole derivatives |
| 04/27/2005 | CN1198793C Ethers of methyl venlafaxine |
| 04/27/2005 | CN1198628C Conditioned cell culture medium compositions and method of use |
| 04/27/2005 | CN1198625C Pharmaceutical compositions for treatment of mucositis, stomatitis and Behchet's syndrome |
| 04/27/2005 | CN1198620C Clathrates of dehydroepindrosterone and corresponding pharmaceutical compositions |
| 04/27/2005 | CN1198618C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/26/2005 | US6884907 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 04/26/2005 | US6884807 3-bicyclic carbocyclic group substituted quinuclidine derivatives, which are cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptor and transporters |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884801 Nitrogen compounds such as N-(4,5-dihydro-1H-imidazol-2-yl-methyl)-2-(methylsulfonyl)aniline, used for prophylaxis of incontinence |
| 04/26/2005 | US6884795 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 04/26/2005 | US6884793 Combination preparation for contraception based on natural estrogens |
| 04/26/2005 | US6884440 Sodium metasilicate, borax,sodium thiosulfate, potassium carbonate, refined cane sugar and water; improvement in disease resistance, weight gain rate, crop yield, crop quality, and harvest time |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/26/2005 | CA2216810C Method for treatment of benign prostatic hypertrophy |
| 04/21/2005 | WO2005035517A1 (3r, 4r)-trans-3,4-diarylchroman derivatives with estrogenic activity |
| 04/21/2005 | WO2005035503A1 Novel isoquinoline derivative |
| 04/21/2005 | WO2005035498A1 Use of nitrogenous bicyclic compound as feeding control agent |
| 04/21/2005 | WO2005034987A1 Use of lh for generating libido and reaching orgasm in female subjects |
| 04/21/2005 | WO2005034970A1 Use of probiotic bacteria in the treatment of infection |
| 04/21/2005 | WO2002092841A3 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
| 04/21/2005 | US20050085639 Circulation disorders; antiproliferative agents; hypotensive agents; cardiovascular disorders; antiischemic agents; kidney disorders; atherosclerosis; restenosis; antiinflammatory agents; respiratory system disorders; angiogenesis inhibitors; anticancer agents; antiulcer agents |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050085469 Fused bicyclic pyrimidine derivatives |
| 04/21/2005 | US20050085461 Benzenesulfonamide derivatives |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | US20050085456 Compounds useful in therapy |
| 04/21/2005 | US20050085440 Formulation |
| 04/21/2005 | US20050085412 Hydrosilation of follicle stimulating hormone; efficiency |
| 04/21/2005 | US20050084518 For producing beautiful skin and improving constipation, reducing hair loss |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | CA2540838A1 Process for the synchronization of ovulation for timed breeding without heat detection |
| 04/21/2005 | CA2539502A1 (3r,4r)-trans-3,4-diarylchroman derivatives with estrogenic activity |
| 04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/2005 | EP1523325A2 Methods and compositions for treating polycystic ovary syndrome |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1523316A2 Combination comprising an hmg-coa reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 04/20/2005 | EP1523303A1 Medicaments containing vardenafil hydrochloride trihydrate |
| 04/20/2005 | EP1226110B1 Bicyclic amino acids as pharmaceutical agents |
| 04/20/2005 | EP1196184B1 Compositions for treatment of sexual dysfunction |
| 04/20/2005 | EP1015431B1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 04/20/2005 | CN1608079A Chemically-modified human growth hormone conjugates |
| 04/20/2005 | CN1608078A Gonadotrophins for folliculogenesis |
| 04/20/2005 | CN1608069A Selective androgen receptor modulators and methods for their identification, design and use |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1608061A Therapeutic isoquinoline compounds |
| 04/20/2005 | CN1608060A Diaryl 1, 2, 4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1608059A Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1607954A Pregnane steroids for use in the treatment of cns dysfunction |
| 04/20/2005 | CN1607944A Pre-formulation for the tabletting of natural mixtures of conjugated estrogens |
| 04/20/2005 | CN1607943A Matrix film tablet with controlled release of a natural mixture of conjugated estrogens |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/20/2005 | CN1606982A Fluconazole formulation |
| 04/20/2005 | CN1606981A Use of phentolamine mesylate as therapeutic agent of feminine sterility |
| 04/20/2005 | CN1197968C Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 04/20/2005 | CN1197967C Gene sequence of rockfish pituitary rich in reproductive control factor and its use |
| 04/20/2005 | CN1197849C 2, 3, 4, 5-tetrahydro-1H-[1, 4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 04/20/2005 | CN1197622C Emulsion-type lubricant for medical appliance and its application in medical rubber product |
| 04/20/2005 | CN1197609C Chinese medicine for treating impotence and its preparation method |
| 04/20/2005 | CN1197607C Hemostat for treating dysfunctional uterina bleeding and bleeding after putting intrauterine device and its preparing method |
| 04/20/2005 | CN1197602C External medicine for treating sterility and women's diseases and its prepn |
| 04/20/2005 | CN1197576C Medicine for treating venereal wart and its preparation method |
| 04/20/2005 | CN1197571C Metronidazole preparation and its preparing method |
| 04/20/2005 | CN1197563C Compound composition for curing male's sterility |
| 04/19/2005 | US6881735 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/19/2005 | US6881728 14-β, 17-α-hydroxymethylandrostane derivatives as androgens |
| 04/19/2005 | US6881405 Reagents and methods for inducing an immune response to prostate specific antigen |
| 04/14/2005 | WO2005033254A1 Body fat burn spurring perfume composition |
| 04/14/2005 | WO2005032558A1 Extended triphasic contraceptive regimens |
| 04/14/2005 | WO2004092215A3 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
| 04/14/2005 | WO2004071427A3 Screening and treatment methods for prevention of preterm delivery |
| 04/14/2005 | US20050080257 Benzo'fisoindole derivatives with affinity to the ep4 receptor |
| 04/14/2005 | US20050080129 Derivatives of andrimide and moiramide b having antibacterial properties |
| 04/14/2005 | US20050080117 Substituted benzoxazoles as estrogenic agents |
| 04/14/2005 | US20050080104 Preparing 3-[(4S)-5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl]benzonitrile by reacting an ester of 4,4,4-trifluoro-3-oxobutanoate with 1,3-cyclohexanedione and 3-cyanobenzaldehyde, , dehydrating and de-esterifying the intermeidate |
| 04/14/2005 | US20050080099 Methods and kits for treating depression or preventing deterioration of cognitive function |
| 04/14/2005 | US20050080073 Sulfonylaminocarboxiylic acid N-arylamides as guanylate cyclase activators |